"High blood flow" versus "low blood flow" ECCOR: how to classify-author's reply.
作者信息
Monet Clément, De Jong Audrey, Jaber Samir
机构信息
Department of Anaesthesiology and Critical Care Medicine B (DAR B), Saint-Eloi Hospital, University Teaching Hospital of Montpellier, PhyMed Exp, INSERM U1046 Montpellier, University of Montpellier, Montpellier, France.
出版信息
Crit Care. 2025 Apr 18;29(1):156. doi: 10.1186/s13054-025-05386-8.
Abstract
摘要
相似文献
1
"High blood flow" versus "low blood flow" ECCOR: how to classify-author's reply.
Crit Care. 2025 Apr 18;29(1):156. doi: 10.1186/s13054-025-05386-8.
2
Feasibility and safety of ultra-low volume ventilation (≤ 3 ml/kg) combined with extra corporeal carbon dioxide removal (ECCOR) in acute respiratory failure patients.
Crit Care. 2024 Dec 27;28(1):433. doi: 10.1186/s13054-024-05168-8.
3
Author's response: "Long term feasibility of ultraprotective lung ventilation with low flow extracorporeal carbon dioxide removal (ECCOR) in ARDS patients".
J Crit Care. 2023 Apr;74:154243. doi: 10.1016/j.jcrc.2022.154243. Epub 2023 Jan 4.
4
Adverse effects of extracorporeal carbon dioxide removal (ECCO2R) for acute respiratory failure: a systematic review protocol.
Syst Rev. 2016 Jun 7;5:98. doi: 10.1186/s13643-016-0270-0.
5
Author's Reply to Letter About: How to Write a Systematic Review and Meta-Analysis.
Dis Colon Rectum. 2025 Jul 1;68(7):e1088. doi: 10.1097/DCR.0000000000003767. Epub 2025 Mar 26.
6
Author's reply to "How to indicate left atrial posterior wall isolation adjunctive to conventional pulmonary vein isolation in patients with atrial fibrillation".
J Cardiol. 2025 Jul;86(1):107. doi: 10.1016/j.jjcc.2025.02.015. Epub 2025 Feb 15.
7
Author's reply to the Letter to the Editor "How to demonstrate the causal relationship between sodium-glucose cotransporter 2 receptor and prevention of ventricular arrhythmia in heart failure cohorts".
J Cardiol. 2025 Jul;86(1):104. doi: 10.1016/j.jjcc.2025.01.012. Epub 2025 Jan 31.
8
A mock circulation loop to test extracorporeal CO elimination setups.
Intensive Care Med Exp. 2020 Sep 11;8(1):52. doi: 10.1186/s40635-020-00341-z.
9
Low-flow assessment of current ECMO/ECCOR rotary blood pumps and the potential effect on hemocompatibility.
Crit Care. 2019 Nov 6;23(1):348. doi: 10.1186/s13054-019-2622-3.
10
High- versus Low-Flow Extracorporeal Respiratory Support in Experimental Hypoxemic Acute Lung Injury.
Am J Respir Crit Care Med. 2023 May 1;207(9):1183-1193. doi: 10.1164/rccm.202212-2194OC.
本文引用的文献
1
Questioning the classification of "high blood flow" versus "low blood flow" ECCO₂R in ultra-low tidal volume ventilation studies: a call for functional classification.
Crit Care. 2025 Mar 19;29(1):121. doi: 10.1186/s13054-025-05352-4.
2
Feasibility and safety of ultra-low volume ventilation (≤ 3 ml/kg) combined with extra corporeal carbon dioxide removal (ECCOR) in acute respiratory failure patients.
Crit Care. 2024 Dec 27;28(1):433. doi: 10.1186/s13054-024-05168-8.
3
Ceremonial purification: which rite is right in liver failure? Author's reply.
Intensive Care Med. 2023 Mar;49(3):367-368. doi: 10.1007/s00134-022-06971-z. Epub 2023 Jan 20.
4
Performance of the decarboxylation index to predict CO removal and minute ventilation reduction under extracorporeal respiratory support.
Artif Organs. 2023 May;47(5):854-863. doi: 10.1111/aor.14471. Epub 2022 Dec 2.
5
Artificial liver support in patients with liver failure: a modified DELPHI consensus of international experts.
Intensive Care Med. 2022 Oct;48(10):1352-1367. doi: 10.1007/s00134-022-06802-1. Epub 2022 Sep 6.
6
Delivering optimal renal replacement therapy to critically ill patients with acute kidney injury.
Intensive Care Med. 2022 Oct;48(10):1368-1381. doi: 10.1007/s00134-022-06851-6. Epub 2022 Sep 6.
7
Extracorporeal carbon dioxide removal for acute respiratory failure: a review of potential indications, clinical practice and open research questions.
Intensive Care Med. 2022 Oct;48(10):1308-1321. doi: 10.1007/s00134-022-06796-w. Epub 2022 Aug 9.
8
Extracorporeal life support for adults with acute respiratory distress syndrome.
Intensive Care Med. 2020 Dec;46(12):2464-2476. doi: 10.1007/s00134-020-06290-1. Epub 2020 Nov 2.
9
Determinants of the effect of extracorporeal carbon dioxide removal in the SUPERNOVA trial: implications for trial design.
Intensive Care Med. 2019 Sep;45(9):1219-1230. doi: 10.1007/s00134-019-05708-9. Epub 2019 Aug 20.
10
Efficacy and safety of lower versus higher CO extraction devices to allow ultraprotective ventilation: secondary analysis of the SUPERNOVA study.
Thorax. 2019 Dec;74(12):1179-1181. doi: 10.1136/thoraxjnl-2019-213591. Epub 2019 Aug 13.
Zotero 插件